Cargando…
Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
Novel series of amidines were synthesized via the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1H)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analys...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716094/ https://www.ncbi.nlm.nih.gov/pubmed/36465858 http://dx.doi.org/10.3389/fchem.2022.1039176 |
_version_ | 1784842606077804544 |
---|---|
author | El-Sheref, Essmat M. Tawfeek, Hendawy N. Hassan, Alaa A. Bräse, S. Elbastawesy, Mohammed A. I. Gomaa, Hesham A. M. Mostafa, Yaser A. Youssif, Bahaa G. M. |
author_facet | El-Sheref, Essmat M. Tawfeek, Hendawy N. Hassan, Alaa A. Bräse, S. Elbastawesy, Mohammed A. I. Gomaa, Hesham A. M. Mostafa, Yaser A. Youssif, Bahaa G. M. |
author_sort | El-Sheref, Essmat M. |
collection | PubMed |
description | Novel series of amidines were synthesized via the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1H)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analysis. The reaction conditions were optimized using cyclohexanone (2), piperidine (3a), and 4-azido-quinolin-2(1H)-one (1a) under an air atmosphere. The new compounds 4a-l and 5a-c were tested for antiproliferative activity against four cancer cell lines using doxorubicin as a reference drug. The most potent derivatives were compounds 4b, 4d, 4e, 4i, and 5c, with GI(50) ranging from 1.00 µM to 1.50 µM. Compound 5c was the most effective derivative against the four cancer cell lines, outperforming doxorubicin. The compounds 4b, 4d, 4e, 4i, and 5c were studied further as topoisomerase I and IIα inhibitors. The compounds tested showed selective inhibition of topo I over topo IIα. Finally, docking studies explain why these compounds prefer topo I over topo IIα. |
format | Online Article Text |
id | pubmed-9716094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97160942022-12-03 Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties El-Sheref, Essmat M. Tawfeek, Hendawy N. Hassan, Alaa A. Bräse, S. Elbastawesy, Mohammed A. I. Gomaa, Hesham A. M. Mostafa, Yaser A. Youssif, Bahaa G. M. Front Chem Chemistry Novel series of amidines were synthesized via the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1H)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analysis. The reaction conditions were optimized using cyclohexanone (2), piperidine (3a), and 4-azido-quinolin-2(1H)-one (1a) under an air atmosphere. The new compounds 4a-l and 5a-c were tested for antiproliferative activity against four cancer cell lines using doxorubicin as a reference drug. The most potent derivatives were compounds 4b, 4d, 4e, 4i, and 5c, with GI(50) ranging from 1.00 µM to 1.50 µM. Compound 5c was the most effective derivative against the four cancer cell lines, outperforming doxorubicin. The compounds 4b, 4d, 4e, 4i, and 5c were studied further as topoisomerase I and IIα inhibitors. The compounds tested showed selective inhibition of topo I over topo IIα. Finally, docking studies explain why these compounds prefer topo I over topo IIα. Frontiers Media S.A. 2022-11-18 /pmc/articles/PMC9716094/ /pubmed/36465858 http://dx.doi.org/10.3389/fchem.2022.1039176 Text en Copyright © 2022 El-Sheref, Tawfeek, Hassan, Bräse, Elbastawesy, Gomaa, Mostafa and Youssif. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Chemistry El-Sheref, Essmat M. Tawfeek, Hendawy N. Hassan, Alaa A. Bräse, S. Elbastawesy, Mohammed A. I. Gomaa, Hesham A. M. Mostafa, Yaser A. Youssif, Bahaa G. M. Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties |
title | Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties |
title_full | Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties |
title_fullStr | Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties |
title_full_unstemmed | Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties |
title_short | Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties |
title_sort | synthesis of novel amidines via one-pot three component reactions: selective topoisomerase i inhibitors with antiproliferative properties |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716094/ https://www.ncbi.nlm.nih.gov/pubmed/36465858 http://dx.doi.org/10.3389/fchem.2022.1039176 |
work_keys_str_mv | AT elsherefessmatm synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT tawfeekhendawyn synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT hassanalaaa synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT brases synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT elbastawesymohammedai synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT gomaaheshamam synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT mostafayasera synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties AT youssifbahaagm synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties |